Do people with multiple sclerosis in Saudi Arabia want to know their prognosis? A cross-sectional nationwide study

References

1. 1.↵
   1. Mross K,
   2. Jankowska M,
   3. Meller A,
   4. Machowska-Sempruch K,
   5. Nowacki P,
   6. Masztalewicz M, et al.

   Sensory integration disorders in patients with multiple sclerosis. J Clin Med 2022; 11:5183.

   OpenUrlPubMed
2. 2.↵
   1. Cotsapas C,
   2. Mitrovic M,
   3. Hafler D.

   Multiple sclerosis. Handb Clin Neurol 2018; 148: 723-730.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Lemus HN,
   2. Warrington AE,
   3. Rodriguez M.

   Multiple sclerosis: Mechanisms of disease and strategies for myelin and axonal repair. Neurol Clin 2018; 36: 1-11.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Sand IK.

   Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol 2015; 28: 193-205.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Klineova S,
   2. Lublin FD.

   Clinical course of multiple sclerosis. Cold Spring Harb Perspect Med 2018; 8.
6. 6.↵
   1. Voloshina N,
   2. Vasylovskiy V,
   3. Negreba T,
   4. Sukhorukov V,
   5. Kirzhner V.

   [Clinical-mathematical analysis of interrelations between a character of the prognosis and peculiarities of onsets in different types of multiple sclerosis course]. Georgian Med News 2021; 318: 132-138.

   OpenUrl
7. 7.↵
   National Institute for Health and Care Excellence guideline [NG220]. Multiple sclerosis in adults: management. NICE; London (United Kingdom): 2022. 1-55. from URL: https://www.nice.org.uk/guidance/ng220
8. 8.↵
   1. Dennison L,
   2. McCloy Smith E,
   3. Bradbury K,
   4. Galea I.

   How do people with multiple sclerosis experience prognostic uncertainty and prognosis communication? A qualitative study. PLoS One 2016; 11.
9. 9.↵
   1. Heesen C,
   2. Gaissmaier W,
   3. Nguyen F,
   4. Stellmann JP,
   5. Kasper J,
   6. Köpke S, et al.

   Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool. PLoS One 2013; 8.
10. 10.↵
    1. Dennison L,
    2. Brown M,
    3. Kirby S,
    4. Galea I.

    Do people with multiple sclerosis want to know their prognosis? A UK nationwide study. PLoS One 2018; 13: e0193407.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Buecken R,
    2. Galushko M,
    3. Golla H,
    4. Strupp J,
    5. Hahn M,
    6. Ernstmann N, et al.

    Patients feeling severely affected by multiple sclerosis: how do patients want to communicate about end-of-life issues? Patient Educ Couns 2012; 88: 318-324.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Lee CY,
    2. Chan KH.

    Personalized use of disease-modifying therapies in multiple sclerosis. Pharmaceutics 2024; 16: 120.

    OpenUrlPubMed
13. 13.↵
    1. Travers BS,
    2. Tsang BKT,
    3. Barton JL.

    Multiple sclerosis: Diagnosis, disease-modifying therapy and prognosis. Aust J Gen Pract 2022; 51: 199-206.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Bashamakh LF,
    2. Alsharif SM,
    3. Wayyani LA,
    4. Alghamdi AE,
    5. Fatani GM,
    6. Alnajashi HA, et al.

    Awareness of patients with multiple sclerosis in Saudi Arabia regarding the relationship between smoking and multiple sclerosis. Neurosciences (Riyadh) 2019; 24: 278-283.

    OpenUrlPubMed
15. 15.↵
    1. Makkawi S,
    2. AlHarbi FA,
    3. Alsulaimani N,
    4. Brashi R,
    5. Melebary R,
    6. Aljabri S, et al.

    The relationship between smoking and multiple sclerosis severity in Saudi Arabia. Cureus 2022; 14: e24181.

    OpenUrlPubMed
16. 16.↵
    1. Cockburn N,
    2. Pateman K,
    3. Taing MW,
    4. Pradhan A,
    5. Ford PJ.

    Managing the oral side-effects of medications used to treat multiple sclerosis. Aust Dent J 2017; 62: 331-336.

    OpenUrlPubMed
17. 17.↵
    1. Daumer M,
    2. Neuhaus A,
    3. Lederer C,
    4. Scholz M,
    5. Wolinsky JS,
    6. Heiderhoff M.

    Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple Sclerosis. BMC Med Inform Decis Mak 2007; 7.
18. 18.↵
    1. Kosch R,
    2. Schiffmann I,
    3. Daumer M,
    4. Lederer C,
    5. Scalfari A,
    6. Galea I, et al.

    Long-term prognostic counselling in people with multiple sclerosis using an online analytical processing tool. Multiple Sclerosis Journal 2020; 27: 1442-1450.

    OpenUrlPubMed